Titan Pharmaceuticals
TTNP
#10596
Rank
โ‚ฌ5.29 M
Marketcap
3,98ย โ‚ฌ
Share price
-3.76%
Change (1 day)
15.73%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -4,00ย โ‚ฌ

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -3,79ย โ‚ฌ. In 2023 the company made an earnings per share (EPS) of -6,39ย โ‚ฌ an increase over its 2022 EPS that were of -13,11ย โ‚ฌ.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-4,00ย โ‚ฌ
2023-6,39ย โ‚ฌ-51.22%
2022-13,11ย โ‚ฌ-15.61%
2021-15,53ย โ‚ฌ-81.37%
2020-83,35ย โ‚ฌ-77.52%
2019-370,83ย โ‚ฌ-56.32%
2018-849,00ย โ‚ฌ-59.51%
2017-2.097ย โ‚ฌ-371.81%
2016771,50ย โ‚ฌ-144.35%
2015-1.739ย โ‚ฌ300%
2014-434,85ย โ‚ฌ-121.54%
20132.019ย โ‚ฌ-151.38%
2012-3.929ย โ‚ฌ-11.54%
2011-4.442ย โ‚ฌ188.89%
2010-1.538ย โ‚ฌ-10%
2009-1.708ย โ‚ฌ
2007-7.004ย โ‚ฌ-2.38%
2006-7.175ย โ‚ฌ-39.13%
2005-11.788ย โ‚ฌ-16.87%
2004-14.179ย โ‚ฌ-22.43%
2003-18.279ย โ‚ฌ4.9%
2002-17.425ย โ‚ฌ61.9%
2001-10.763ย โ‚ฌ-13.7%
2000-12.471ย โ‚ฌ68.94%
1999-7.382ย โ‚ฌ-35.87%
1998-11.511ย โ‚ฌ-1824.71%
1997667,42ย โ‚ฌ-102.4%
1996-27.865ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,54ย โ‚ฌ-299.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,06ย โ‚ฌ-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-1,23ย โ‚ฌ-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
0,79ย โ‚ฌ-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-0,22ย โ‚ฌ-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-3,36ย โ‚ฌ-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA